Wells Fargo analyst Derek Archila raised the firm’s price target on Argenx to $609 from $606 and keeps an Overweight rating on the shares following the Q2 results. Wells Fargo expects shares to continue to grind higher on solid commercial execution and ahead of ITP/PV results in Q4, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ARGX:
- Next major rally in biotech likely not until end of 2024, says Capital One
- argenx Reports Half Year 2023 Financial Results and Provides Second Quarter Business Update
- argenx announces closing of global offering
- Argenx price target raised to $575 from $545 at Piper Sandler
- Argenx downgraded to Neutral from Buy at UBS